Rhythm Pharmaceuticals, Inc. financial data

Symbol
RYTM on Nasdaq
Location
222 Berkeley Street, 12 Th Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 347 % -26.9%
Quick Ratio 17.1 % +4.26%
Debt-to-equity 508 % +85.1%
Return On Equity -433 % -17.9%
Return On Assets -46.4 % +40.1%
Operating Margin -107 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66.7M shares +8.59%
Common Stock, Shares, Outstanding 66.7M shares +8.54%
Entity Public Float 2.4B USD +171%
Common Stock, Value, Issued 67K USD +9.84%
Weighted Average Number of Shares Outstanding, Basic 66.3M shares +8.23%
Weighted Average Number of Shares Outstanding, Diluted 66.3M shares +8.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 174M USD +54.3%
Research and Development Expense 166M USD -26.6%
Costs and Expenses 361M USD -4.63%
Operating Income (Loss) -186M USD +29.9%
Nonoperating Income (Expense) -5.72M USD -179%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -192M USD +25.7%
Income Tax Expense (Benefit) 439K USD
Net Income (Loss) Attributable to Parent -192M USD +25.7%
Earnings Per Share, Basic -3 USD/shares +28.6%
Earnings Per Share, Diluted -3 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.1M USD +9.59%
Cash, Cash Equivalents, and Short-term Investments 416M USD +39.4%
Accounts Receivable, after Allowance for Credit Loss, Current 33M USD +71.1%
Inventory, Net 22.1M USD +59.1%
Other Assets, Current 8.8M USD +31.9%
Assets, Current 495M USD +45.4%
Other Long-term Investments 2.47M USD -79.4%
Property, Plant and Equipment, Net 237K USD -70.4%
Operating Lease, Right-of-Use Asset 3.16M USD -12%
Other Assets, Noncurrent 7.33M USD -51.2%
Assets 507M USD +39.4%
Accounts Payable, Current 13.6M USD +179%
Accrued Liabilities, Current 59.3M USD +33.2%
Liabilities, Current 104M USD +6.83%
Operating Lease, Liability, Noncurrent 3.52M USD -12.8%
Other Liabilities, Noncurrent 35.6M USD
Liabilities 211M USD +0.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -926K USD -53.3%
Retained Earnings (Accumulated Deficit) -1.3B USD -17.3%
Stockholders' Equity Attributable to Parent 149M USD +1227%
Liabilities and Equity 507M USD +39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -40.4M USD +0.96%
Net Cash Provided by (Used in) Financing Activities 32.5M USD +666%
Net Cash Provided by (Used in) Investing Activities 24.8M USD -17.4%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 66.7M shares +8.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17M USD
Deferred Tax Assets, Valuation Allowance 326M USD +21.8%
Deferred Tax Assets, Gross 327M USD +22.1%
Operating Lease, Liability 4.03M USD +180%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -198M USD +24.4%
Lessee, Operating Lease, Liability, to be Paid 5.91M USD +278%
Property, Plant and Equipment, Gross 5.4M USD -0.02%
Operating Lease, Liability, Current 624K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.1M USD +120%
Lessee, Operating Lease, Liability, to be Paid, Year One 456K USD -46.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD +1415%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD
Deferred Tax Assets, Operating Loss Carryforwards 167M USD +8.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.15M USD
Additional Paid in Capital 1.45B USD +29.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.2M USD +255%
Interest Expense 15.6M USD +55.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%